Possible molecular target therapy with rapamycin in MDS.
Maeda Y, Yamaguchi T, Hijikata Y, Matsuoka T, Tanaka M, Morita Y, Hirase C, Takai S, Tatsumi Y, Matsuda M, Kanamaru A.
Maeda Y, et al.
Leuk Lymphoma. 2006 May;47(5):907-11. doi: 10.1080/10428190500467859.
Leuk Lymphoma. 2006.
PMID: 16753877